1. HPTLC analysis of a new ultra-short-acting thiazolodiazepine hypnotic (HIE-124) in spiked human plasma
- Author
-
Ehab A. Abourashed, Hussein I. El-Subbagh, and Mohamed M. Hefnawy
- Subjects
Detection limit ,Hypnotic ,Chromatography ,Resolution (mass spectrometry) ,Chemistry ,Human plasma ,medicine.drug_class ,Clinical Biochemistry ,medicine ,Densitometry ,Biochemistry ,Quantitative analysis (chemistry) ,Analytical Chemistry - Abstract
Summary Ethyl 8-oxo-5,6,7,8-tetrahydrothiazolo[3,2-a][1,3]diazepin-3-carboxylate (HIE-124) is one of a new generation of ultra-short-acting hypnotics. A high-performance thin-layer chromatographic (HPTLC) method has been established as the first reported method for quantitative analysis of HIE-124 in plasma. Baseline resolution between HIE-124 and diazepam (internal standard) was achieved on HPTLC plates with chloroform–ethyl acetate 80:20 (v/v) as mobile phase. Densitometric detection was performed at 265 nm. The method was linear in the range 40–400 μg mL–1 (R = 0.997) and recoveries of the drug were in the range 93–102% at 80– 350 μg mL –1 . Within-run and between-run precision calculated as RSD [%], and accuracy calculated as percentage error were in the ranges 2.1–4.6% and 0.8–6.9%, respectively. The limits of detection (LOD) and quantification (LOQ) in spiked human plasma were 20 and 40 μg mL–1 (40 and 80 ng per band), respectively.
- Published
- 2009
- Full Text
- View/download PDF